Table 1.
Characteristics of the population from hospitals with consistent submissions by financial year 08/09–16/17 – patients with an ISS ≥ 9.
| 2008/09 | 2009/10 | 2010/11 | 2011/12 | 2012/13 | 2013/14 | 2014/15 | 2015/16 | 2016/17 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals submitting to TARN | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 |
| TARN cases | 5338 | 6957 | 8626 | 9679 | 11,708 | 14,793 | 16,414 | 18,151 | 19,197 | 110,863 |
| Age, median (IQR) | 45 (25.8–63.2) | 47.9 (27.2–66) | 48.3 (28.1–66.3) | 48.9 (28.2–67.7) | 52.8 (31.2–72.7) | 54.7 (33–75.1) | 56.7 (34.6–76.7) | 57.5 (35.2–77.9) | 59 (36.5–78.5) | 54.2 (32–74.5) |
| Age > 64, n (%) | 1160 (21.7%) | 1787 (25.7%) | 2253 (26.1%) | 2710 (28%) | 3835 (32.8%) | 5248 (35.5%) | 6330 (38.6%) | 7261 (40%) | 8056 (42%) | 38,640 (34.9%) |
| Male, n (%) | 3621 (67.8%) | 4613 (66.3%) | 5633 (65.3%) | 6377 (65.9%) | 7340 (62.7%) | 9276 (62.7%) | 10,152 (61.8%) | 11,271 (62.1%) | 11,715 (61%) | 69,998 (63.1%) |
| ISS, median (IQR) | 14 (9–24) | 16 (9–25) | 16 (9–25) | 16 (9–25) | 14 (9–24) | 14 (9–25) | 14 (9–25) | 16 (9–25) | 16 (9–25) | 16 (9–25) |
| First hospital GCS, median (IQR) | 15 (14–15) | 15 (14–15) | 15 (14–15) | 15 (14–15) | 15 (14–15) | 15 (14–15) | 15 (14–15) | 15 (14–15) | 15 (14–15) | 15 (14–15) |
| RTC, n (%) | 1833 (34.3%) | 2223 (32%) | 2622 (30.4%) | 3041 (31.4%) | 3343 (28.6%) | 4204 (28.4%) | 4581 (27.9%) | 4887 (26.9%) | 5044 (26.3%) | 31,778 (28.7%) |
| High fall, n (%) | 874 (16.4%) | 1099 (15.8%) | 1405 (16.3%) | 1489 (15.4%) | 1737 (14.8%) | 2256 (15.3%) | 2521 (15.4%) | 2616 (14.4%) | 2730 (14.2%) | 16,727 (15.1%) |
| Low fall, n (%) | 1706 (32%) | 2492 (35.8%) | 3108 (36%) | 3624 (37.4%) | 5022 (42.9%) | 6413 (43.4%) | 7354 (44.8%) | 8441 (46.5%) | 9064 (47.2%) | 47,224 (42.6%) |
| Other, n (%) | 393 (7.4%) | 463 (6.7%) | 591 (6.9%) | 635 (6.6%) | 720 (6.1%) | 882 (6%) | 862 (5.3%) | 956 (5.3%) | 938 (4.9%) | 6440 (5.8%) |
| Assault, n (%) | 532 (10%) | 680 (9.8%) | 900 (10.4%) | 890 (9.2%) | 886 (7.6%) | 1038 (7%) | 1096 (6.7%) | 1251 (6.9%) | 1421 (7.4%) | 8694 (7.8%) |
| Penetrating, n (%) | 367 (6.9%) | 419 (6%) | 508 (5.9%) | 563 (5.8%) | 567 (4.8%) | 605 (4.1%) | 603 (3.7%) | 811 (4.5%) | 900 (4.7%) | 5343 (4.8%) |
| TBI, n (%) | 1887 (36.6%) | 2472 (36.7%) | 2915 (36%) | 3166 (35.1%) | 3515 (33%) | 4483 (33.4%) | 5012 (33.8%) | 5655 (34.7%) | 6073 (35%) | 35,178 (34.6%) |
| Extracranial, n (%) | 3650 (70.7%) | 4804 (71.3%) | 5869 (72.4%) | 6584 (73%) | 7830 (73.4%) | 9827 (73.2%) | 10,863 (73.2%) | 11,752 (72.2%) | 12,462 (71.8%) | 73,641 (72.5%) |
| Comorbidity present, n (%) | 2119 (39.7%) | 3051 (43.9%) | 4083 (47.3%) | 4936 (51%) | 6192 (52.9%) | 8072 (54.6%) | 9497 (57.9%) | 11,417 (62.9%) | 12,257 (63.8%) | 61,624 (55.6%) |